First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: A subgroup analysis of data from the FLEX phase 3 study

Ulrich Gatzemeier, Joachim von Pawel, Ihor Vynnychenko, Petr Zatloukal, Filippo de Marinis, Wilfried E E Eberhardt, Luis Paz-Ares, Karl Maria Schumacher, Thomas Goddemeier, Kenneth J. O'Byrne, Robert Pirker

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: A subgroup analysis of data from the FLEX phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences